⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

David VallanceM.D.

Rheumatology · Ann Arbor, MI 48105

NPI: 1285618231

Share:

37

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peersHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

9,479

Total Claims

$2.6M

Drug Cost

427

Beneficiaries

$5,988

Cost/Patient

Risk Score Breakdown 37/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Cost per patient outlier+3
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+446%

Opioid rate vs peers

22.2% vs 4.1% avg

-1%

Cost per patient vs peers

$5,988 vs $6,039 avg

+24%

Brand preference vs peers

9.4% vs 7.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

💊

Opioid rate is 446% above Rheumatology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

22.2%

Opioid Rate

2,101

Opioid Claims

$152K

Opioid Cost

29.3%

Long-Acting Rate

This provider's opioid prescribing rate of 22.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

91% generic

Brand: 876 claims · $2.1M

Generic: 8,459 claims · $396K

Patient Profile

69

Avg Age

79%

Female

1.48

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About